Platelets in cardiovascular imaging

Current Vascular Pharmacology

Volumn 10, Issue 5, 2012, Pages 619-625

  Schuster, Andreas ^a,b   Makowski, Marcus R ^a,b,c   Jansen, Christian H P ^a,b   Gawaz, Meinrad ^d   Botnar, Rene M ^a,b   Nagel, Eike ^a,b   Bigalke, Boris ^a,b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Atherosclerosis; Cardiac magnetic resonance imaging; Coronary artery disease; Non invasive imaging; Platelets; Vulnerable plaque

Indexed keywords

D DIMER; EPTIFIBATIDE; GADOLINIUM PENTETATE; GADOTERIC ACID; INDIUM 111; IODINATED CONTRAST MEDIUM; TECHNETIUM 99M; UROKINASE;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; CARDIOVASCULAR MAGNETIC RESONANCE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY THROMBOSIS; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; HUMAN; INTRAVASCULAR ULTRASOUND; LUNG EMBOLISM; MOLECULAR PROBE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ANIMALS; BLOOD PLATELETS; CARDIAC IMAGING TECHNIQUES; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; CORONARY ARTERY DISEASE; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HUMANS; MAGNETIC RESONANCE IMAGING; PLATELET ACTIVATION; THROMBOSIS;

EID: 84864572045     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016112801784620     Document Type: Review

References (73)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-504.
2. Widimsky P, Wijns W, Fajadet J, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 2010; 31: 943-57.
3. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation 2010; 121: e46-e215.
4. Dey S, Flather MD, Devlin G, et al. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart 2009; 95: 20-6.
5. Rothman M, De Palma R. Delays in angiography may cost lives. Heart 2009; 95: 1815-7.
6. Swanson N, Montalescot G, Eagle KA, et al. Delay to angiography and outcomes following presentation with high-risk, non-STelevation acute coronary syndromes: results from the Global Registry of Acute Coronary Events. Heart 2009; 95: 211-5.
7. Hoffmann U, Bamberg F. Is computed tomography coronary angiography the most accurate and effective non-invasive imaging tool to evaluate patients with acute chest pain in the emergency department?: CT coronary angiography is the most accurate and effective non-invasive imaging tool for evaluating patients presenting with chest pain to the emergency department. Circ Cardiovasc Imaging 2009; 2: 251-63.
8. Heller GV, Stowers SA, Hendel RC, et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and non-diagnostic electrocardiograms. J Am Coll Cardiol 1998; 31: 1011-7.
9. Sabia P, Afrookteh A, Touchstone DA, Keller MW, Esquivel L, Kaul S. Value of regional wall motion abnormality in the emergency room diagnosis of acute myocardial infarction. A prospective study using two-dimensional echocardiography. Circulation 1991; 84: I85-92.
10. Bedetti G, Pasanisi EM, Tintori G, et al. Stress echo in chest pain unit: the SPEED trial. Int J Cardiol 2005; 102: 461-7.
11. Schuster A, Morton G, Chiribiri A, Perera D, Vanoverschelde J, Nagel E. Imaging in the management of ischemic cardiomyopathy: special focus on magnetic resonance. J Am Coll Cardiol 2012; 59: 359-70.
12. Morton G, Schuster A, Perera D, Nagel E. Cardiac magnetic resonance imaging to guide complex revascularization in stable coronary artery disease. Eur Heart J 2010; 31: 2209-15.
13. Kwong RY, Schussheim AE, Rekhraj S, et al. Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation 2003; 107: 531-7.
14. Cury RC, Shash K, Nagurney JT, et al. Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. Circulation 2008; 118: 837-44.
15. Giugliano RP, White JA, Bode C, et al. Early vs. delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med 2009; 360: 2176-90.
16. Mehta SR, Granger CB, Boden WE, et al. Early vs. delayed invasive intervention in acute coronary syndromes. N Engl J Med 2009; 360: 2165-75.
17. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1137-40.
18. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006; 47: C7-12.
19. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317-25.
20. Jansen CHP, Perera D, Makowski MR, et al. Detection of intracoronary thrombus by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 2011; 124: 416-24.
21. Vancraeynest D, Pasquet A, Roelants V, Gerber BL, Vanoverschelde JL. Imaging the vulnerable plaque. J Am Coll Cardiol 2011; 57: 1961-79.
22. Tabas I, Williams KJ, Borén J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007; 116: 1832-44.
23. Krettek A, Sukhova GK, Libby P. Elastogenesis in human arterial disease: a role for macrophages in disordered elastin synthesis. Arterioscler Thromb Vasc Biol 2003; 23: 582-7.
24. Yamagishi M, Terashima M, Awano K, et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol 2000; 35: 106-11.
25. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010; 10: 36-46.
26. Sluimer JC, Kolodgie FD, Bijnens AP, et al. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol 2009;53:1517-27.
27. Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003; 349: 2316-25.
28. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-34.
29. Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood. 2003;102:449-61.
30. Bigalke B, Krämer BF, Seizer P, Fateh-Moghadam S, Gawaz M, Lindemann S. Diagnostic and therapeutic potentials of platelet glycoprotein VI. Semin Thromb Hemost 2010; 36: 203-11.
31. Furie B, Furie BC. Thrombus formation in vivo. J Clin Invest 2005; 115: 3355-62.
32. Johnson GA, Benveniste H, Black RD, Hedlund LW, Maronpot RR, Smith BR. Histology by magnetic resonance microscopy. Magn Reson Q 1993; 9: 1-30.
33. Geisler T, Fekecs L, Wurster T, et al. Association of platelet-SDF-1 with hemodynamic function and infarct size using cardiac MR in patients with AMI. Eur J Radiol 2012; 81: e486-90.
34. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999; 99: 2293-352.
35. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 2006; 35: 512.
36. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004; 17: 484-99.
37. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54: 2129-38.
38. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378-84.
39. Peter K, Ahrens I, Schwarz M, Bode C, Ylanne J. Distinct roles of ligand affinity and cytoskeletal anchorage in alphaIIbbeta3 (GP IIb/IIIa)-mediated cell aggregation and adhesion. Platelets 2004; 15: 427-38.
40. Thiele H, Schindler K, Friedenberger J, et al. Intracoronary compared with intravenous bolus abciximab application in patients with STelevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV vs. IC in STelevation myocardial infarction trial. Circulation 2008; 118: 49-57.
41. Klink A, Lancelot E, Ballet S, et al. Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe. Arterioscler Thromb Vasc Biol 2010; 30: 403-10.
42. von zur Muhlen C, von Elverfeldt D, Moeller JA, et al. Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation 2008; 118: 258-67.
43. Farrar CT, Dai G, Novikov M, et al. Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging. NMR Biomed 2008; 21: 453-63.
44. Heidt T, Deininger F, Peter K, et al. Activated platelets in carotid artery thrombosis in mice can be selectively targeted with a radiolabeled single-chain antibody. PLoS ONE 2011; 6: e18446.
45. Zhao C, Shuke N, Okizaki A, et al. Naturally formed coronary arterial thrombus detected by In-111 oxine platelet imaging. Clin Nucl Med 2005; 30: 492-5.
46. Dunzinger A, Hafner F, Schaffler G, Piswanger-Soelkner JC, Brodmann M, Lipp RW. 99mTc-apcitide scintigraphy in patients with clinically suspected deep venous thrombosis and pulmonary embolism. Eur J Nucl Med Mol Imaging 2008; 35: 2082-7.
47. Langer HF, Haubner R, Pichler BJ, Gawaz M. Radionuclide imaging: a molecular key to the atherosclerotic plaque. J Am Coll Cardiol 2008; 52: 1-12.
48. Schulz C, Penz S, Hoffmann C, et al. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol 2008; 103: 356-67.
49. Schönberger T, Siegel-Axel D, Bussl R, et al. The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/-mice. Cardiovasc Res 2008; 80: 131-7.
50. Bigalke B, Pohlmeyer I, Schönberger T, et al. Imaging of injured and atherosclerotic arteries in mice using fluorescence-labeled glycoprotein VI-Fc. Eur J Radiol 2011; 79: e63-9.
51. Bigalke B, Lindemann S, Schönberger T, et al. Ex vivo imaging of injured arteries in rabbits using fluorescence-labelled glycoprotein VI-Fc. Platelets 2012; 23: 1-6.
52. Zeibig S, Li Z, Wagner S, et al. Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis. Circ Res 2011; 108: 695-703.
53. Overoye-Chan K, Koerner S, Looby RJ, et al. EP-2104R: a fibrinspecific gadolinium-Based MRI contrast agent for detection of thrombus. J Am Chem Soc 2008; 130: 6025-39.
54. Botnar RM, Buecker A, Wiethoff AJ, et al. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation 2004; 110: 1463-6.
55. Botnar RM, Perez AS, Witte S, et al. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 2004; 109: 2023-9.
56. Spuentrup E, Buecker A, Katoh M, et al. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation 2005; 111: 1377-82.
57. Flacke S, Fischer S, Scott MJ, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001; 104: 1280-5.
58. Spuentrup E, Botnar RM, Wiethoff A, et al. MR imaging of thrombi using EP-2104R, a fibrin specific contrast agent: initial results in patients. Eur Radiol 2008; 18: 1995-2005.
59. Uppal R, Catana C, Ay I, Benner T, Sorensen AG, Caravan P. Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe--feasibility study in rat model. Radiology 2011; 258: 812-20.
60. Makowski MR, Wiethoff AJ, Blume U, et al. Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nat Med 2011; 17: 383-8.
61. Makowski MR, Varma G, Wiethoff A, et al. Non-invasive assessment of atherosclerotic plaque progression in ApoE-/-mice using susceptibility gradient mapping. Circ Cardiovasc Imaging 2011; 4: 295-303.
62. Amirbekian V, Lipinski MJ, Briley-Saebo KC, et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci USA 2007; 104: 961-6.
63. Hyafil F, Cornily J, Feig J, et al. Non-invasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 2007; 13: 636-41.
64. Lord G, Trembath R. A strategy for translation. Lancet 2007; 369: 1771-3.
65. Schuster A, Grünwald I, Chiribiri A, et al. An isolated perfused pig heart model for the development, validation and translation of novel cardiovascular magnetic resonance techniques. J Cardiovasc Magn Reson 2010; 12: 53.
66. Weinsaft JW, Kim RJ, Ross M, et al. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. JACC Cardiovasc Imaging 2009; 2: 969-79.
67. Morris TA. SPECT imaging of pulmonary emboli with radiolabeled thrombus-specific imaging agents. Semin Nucl Med 2010; 40: 474-9.
68. van Beek EJR, Wild JM, Fink C, Moody AR, Kauczor H-U, Oudkerk M. MRI for the diagnosis of pulmonary embolism. J Magn Reson Imaging 2003; 18: 627-40.
69. Moody AR. Magnetic resonance direct thrombus imaging. J Thromb Haemost 2003; 1: 1403-9.
70. Moody AR. Direct imaging of deep-vein thrombosis with magnetic resonance imaging. Lancet 1997; 350: 1073.
71. Moody AR, Murphy RE, Morgan PS, et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 2003; 107: 3047-52.
72. Kawasaki T, Koga S, Koga N, et al. Characterization of hyperintense plaque with non-contrast T(1)-weighted cardiac magnetic resonance coronary plaque imaging: comparison with multislice computed tomography and intravascular ultrasound. JACC Cardiovasc Imaging 2009; 2: 720-8.
73. Maintz D, Ozgun M, Hoffmeier A, et al. Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. Eur Heart J 2006; 27: 1732-6.